We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Evaluating Novel Therapies in ctDNA Positive GI Cancers (MRD-GI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05482516
Recruitment Status : Recruiting
First Posted : August 1, 2022
Last Update Posted : February 24, 2023
Genentech, Inc.
Natera, Inc.
Information provided by (Responsible Party):
Georgetown University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2026
Estimated Study Completion Date : December 2028